N
CATX icon

Nuveen’s Perspective Therapeutics CATX Stock Holding History

Nuveen’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.8M Sell
910,221
-363,786
-29% -$1.54M ﹤0.01% 1996
2025
Q4 		$3.5M Sell
1,274,007
-34,635
-3% -$98.8K ﹤0.01% 2065
2025
Q3 		$4.49M Sell
1,308,642
-988,672
-43% -$3.6M ﹤0.01% 1954
2025
Q2 		$7.9M Buy
2,297,314
+1,054,772
+85% +$2.78M ﹤0.01% 1649
2025
Q1 		$2.65M Buy
1,242,542
+520,494
+72% +$1.56M ﹤0.01% 2219
2024
Q4 		$2.3M Sell
722,048
-108,165
-13% -$883K ﹤0.01% 2327
2024
Q3 		$11.1M Buy
830,213
+569,286
+218% +$7.57M ﹤0.01% 1539
2024
Q2 		$2.6M Buy
+260,927
New +$3.77M ﹤0.01% 2255

Other funds holding CATX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return